Reichard Mason V, Rugg Jady J, Thomas Jennifer E, Allen Kelly E, Barrett Annie W, Murray Jill K, Herrin Brian H, Beam Rachel A, King Vickie L, Vatta Adriano F
Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74078, USA.
Zoetis, Veterinary Medicine Research and Development, Kalamazoo, MI 49007, USA.
Vet Parasitol. 2019 Jun;270 Suppl 1:S31-S37. doi: 10.1016/j.vetpar.2018.10.018. Epub 2018 Nov 11.
Cytauxzoonosis, caused by infection with Cytauxzoon felis, is the most severe tick-borne disease of cats. The purpose of our study was to determine the efficacy of selamectin (6.0 mg/kg) plus sarolaner (1.0 mg/kg) formulated in combination (Revolution® Plus / Stronghold Plus, Zoetis) applied topically once a month on cats for three months against induced infestations of Amblyomma americanum adults and to evaluate the effectiveness of the product in preventing the transmission of C. felis. This study was conducted in two phases. Sixteen cats were dosed with selamectin/sarolaner or a placebo (vehicle control) on Days 0, 28, and 56. In phase 1, each cat was infested with 50 (±5) unfed adult A. americanum on Day 4 and tick counts were conducted on Day 6 (48 h post infestation) and Day 7 (72 h post infestation) to evaluate acaricidal efficacy. In phase 2, to confirm acaricidal efficacy and evaluate prevention of C. felis transmission, each cat was infested on Day 60 with 50 (±5) adult A. americanum acquisition fed as nymphs on two C. felis-infected donor cats. Tick counts were conducted on Day 62 (48 h post infestation) and Day 63 (72 h post infestation). Blood samples were collected on Days -9, 60, 70, 76, and 90 and tested for infection with C. felis. Placebo cats were adequately infested on all count days, with least squares (geometric) mean live tick counts ranging from 34.0 (28.8) to 46.1 (46.0). Treatment reduced the least squares (geometric) mean counts compared to placebo by 27.1 (32.1)% and 90.4 (96.8)% on Days 6 and 7, respectively. The corresponding percent reductions were 56.4 (60.6)% and 94.7 (97.3)% on Days 62 and 63, respectively. Least squares mean counts were significantly lower in the treated group compared with the placebo group on all count days (P ≤ 0.0286). All cats were negative for C. felis by PCR prior to study start. In phase 2, seven cats in the control group and no cats in the selamectin/sarolaner group became infected with C. felis (P = 0.0017). Topical treatment with selamectin/sarolaner was >90% effective in reducing A. americanum tick counts 72 h after infestation and prevented the transmission of C. felis from infected ticks following the third of three monthly treatments. Revolution Plus / Stronghold Plus offers an option for the control of A. americanum infestations on cats and for preventing the transmission of C. felis to cats.
由感染猫嗜吞噬细胞无形体(Cytauxzoon felis)引起的嗜吞噬细胞无形体病,是猫最严重的蜱传疾病。我们研究的目的是确定每月一次局部应用于猫连续三个月的赛拉菌素(6.0毫克/千克)加沙罗拉纳(1.0毫克/千克)复方制剂(瑞辉加强版/蚤不到加强版,硕腾公司)对美洲钝眼蜱成虫诱发感染的效果,并评估该产品预防猫嗜吞噬细胞无形体传播的有效性。本研究分两个阶段进行。16只猫在第0天、第28天和第56天接受赛拉菌素/沙罗拉纳或安慰剂(赋形剂对照)给药。在第1阶段,每只猫在第4天感染50只(±5只)未进食的美洲钝眼蜱成虫,并在第6天(感染后48小时)和第7天(感染后72小时)进行蜱计数,以评估杀螨效果。在第2阶段,为确认杀螨效果并评估预防猫嗜吞噬细胞无形体传播的效果,每只猫在第60天感染50只(±5只)曾以若虫形态吸食两只感染猫嗜吞噬细胞无形体的供体猫血液的成虫美洲钝眼蜱。在第62天(感染后48小时)和第63天(感染后72小时)进行蜱计数。在第-9天、第60天、第70天、第76天和第90天采集血样,检测猫嗜吞噬细胞无形体感染情况。在所有计数日,安慰剂组的猫均被充分感染,最小二乘(几何)平均存活蜱计数范围为34.0(28.8)至46.1(46.0)。与安慰剂相比,治疗组在第6天和第7天的最小二乘(几何)平均计数分别降低了27.1(32.1)%和90.4(96.8)%。在第62天和第63天,相应的降低百分比分别为56.4(60.6)%和94.7(97.3)%。在所有计数日,治疗组的最小二乘平均计数均显著低于安慰剂组(P≤0.0286)。在研究开始前,所有猫通过聚合酶链反应检测猫嗜吞噬细胞无形体均为阴性。在第2阶段,对照组有7只猫感染猫嗜吞噬细胞无形体,而赛拉菌素/沙罗拉纳组无猫感染(P = 0.0017)。赛拉菌素/沙罗拉纳局部治疗在感染后72小时减少美洲钝眼蜱计数的效果>90%,并在三个月一次的三次治疗中的第三次治疗后防止了感染蜱将猫嗜吞噬细胞无形体传播给猫。瑞辉加强版/蚤不到加强版为控制猫的美洲钝眼蜱感染以及预防猫嗜吞噬细胞无形体传播给猫提供了一种选择。